Further, the present study suggests no meaningful difference in dementia risk between SGLT2 inhibitors and GLP1 receptor agonists in this population
Continuous treatment preserves the neurobiological changes that GLP-1 medications create in appetite centers and glucose regulation
Peptides might engage with thyroid meds, corticosteroids, insulin or diabetes drugs, growth hormone supplements, and blood-glucose controllers
Breaking news from the Q3 2025 Lilly Earnings Call Eli Lilly just announced a new peptide called Brenipatide, a dual GIP and GLP molecule being studied for alcohol use disorder, asthma, and even opioid dependence
Normal myofiber morphology was observed in controls, with no abnormalities induced by GHRP-6 alone